Select Medical Holdings Corporation (NYSE:SEM) Receives $15.50 Consensus Target Price from Analysts

Select Medical Holdings Corporation (NYSE:SEM) has earned an average rating of “Hold” from the seven research firms that are covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $15.50.

SEM has been the topic of several research reports. Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, March 4th. Wall Street Zen downgraded Select Medical from a “buy” rating to a “hold” rating in a report on Monday, March 9th. Weiss Ratings restated a “hold (c-)” rating on shares of Select Medical in a report on Wednesday, May 20th. Royal Bank Of Canada restated a “sector perform” rating and set a $16.50 price objective (down from $19.00) on shares of Select Medical in a report on Tuesday, March 3rd. Finally, Mizuho reaffirmed a “neutral” rating and set a $16.50 target price (down from $17.00) on shares of Select Medical in a research report on Tuesday, May 12th.

Select Medical Trading Up 0.1%

SEM opened at $16.54 on Thursday. Select Medical has a one year low of $11.65 and a one year high of $16.99. The stock has a market cap of $2.05 billion, a price-to-earnings ratio of 15.61, a P/E/G ratio of 0.95 and a beta of 1.02. The stock’s 50 day moving average price is $16.39 and its 200-day moving average price is $15.52. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.15 and a current ratio of 1.15.

Select Medical (NYSE:SEM) last released its quarterly earnings data on Thursday, April 30th. The health services provider reported $0.36 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.07). The firm had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.41 billion. Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The company’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.44 earnings per share. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. On average, equities analysts forecast that Select Medical will post 1.26 EPS for the current year.

Select Medical Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 28th. Shareholders of record on Thursday, May 14th will be given a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a yield of 1.5%. The ex-dividend date of this dividend is Thursday, May 14th. Select Medical’s dividend payout ratio (DPR) is 23.58%.

Select Medical announced that its Board of Directors has initiated a stock repurchase plan on Thursday, February 19th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the health services provider to reacquire up to 49.5% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s management believes its shares are undervalued.

Institutional Trading of Select Medical

Institutional investors have recently made changes to their positions in the business. Mitsubishi UFJ Trust & Banking Corp raised its stake in Select Medical by 889.7% in the 3rd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 64,094 shares of the health services provider’s stock worth $823,000 after acquiring an additional 57,618 shares during the last quarter. Dana Investment Advisors Inc. raised its stake in Select Medical by 52.9% in the 3rd quarter. Dana Investment Advisors Inc. now owns 524,621 shares of the health services provider’s stock worth $6,736,000 after acquiring an additional 181,436 shares during the last quarter. Public Sector Pension Investment Board raised its stake in shares of Select Medical by 21.3% in the third quarter. Public Sector Pension Investment Board now owns 430,472 shares of the health services provider’s stock worth $5,527,000 after purchasing an additional 75,530 shares during the last quarter. Western Standard LLC purchased a new position in shares of Select Medical in the third quarter worth about $13,551,000. Finally, CSM Advisors LLC raised its stake in shares of Select Medical by 32.0% in the third quarter. CSM Advisors LLC now owns 298,961 shares of the health services provider’s stock worth $3,840,000 after purchasing an additional 72,546 shares during the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.